Skip to main content

Medrysone ophthalmic Pregnancy and Breastfeeding Warnings

Medrysone ophthalmic is also known as: HMS

Medrysone ophthalmic Pregnancy Warnings

Medrysone ophthalmic suspension has been assigned to pregnancy category C by the FDA. Animal data have revealed evidence of fetal resorption in rabbits given 10 to 30 times the recommended human ophthalmic dose. There are no controlled data in human pregnancy. Medrysone ophthalmic is only recommended for use during pregnancy when benefit outweighs risk.

See references

Medrysone ophthalmic Breastfeeding Warnings

There are no data on the excretion of medrysone into human milk. Topically applied steroids have been reported to be absorbed systemically and could suppress infant growth and endogenous corticosteroid production.

See references

References for pregnancy information

  1. "Product Information. HMS (medrysone ophthalmic)." Allergan Inc (2001):

References for breastfeeding information

  1. "Product Information. HMS (medrysone ophthalmic)." Allergan Inc (2001):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.